Cleveland Clinic surgeons describe a new technique for harvesting a rectal mucosa graft.
Cleveland Clinic reconstructive urologists and colorectal surgeons describe for the first time a technique using the single-port (SP) robotic system to harvest a rectal mucosal graft (RMG) in a patient with extensive urethral stricture disease. They reported their initial experience in Urology.
“The SP robot is a great fit for transanal surgery; it marries modern endoscopy with a technologically advanced robotic system. However, it may be unfamiliar territory for some urologists," said Hadley Wood, MD.
Reconstructive urologist Hadley Wood, MD, senior author of the paper and staff in Cleveland Clinic’s Center for Genitourinary Reconstruction, says the technique is a safe and effective option for harvesting RMGs. In addition, the impressive length of the graft, 21 by 3 cm, is believed to be the longest RMG reported in the literature.
An RMG isn’t the preferred choice for reconstructing urethral strictures. But when the tissue inside the cheek, known as a buccal mucosa graft (BMG), is insufficient — an RMG is often a viable alternative.
This was the case for a 57-year-old patient who presented to the emergency department with urgency and urinary retention symptoms and a history of recurrent urinary tract infections. Urethral x-ray revealed a stricture that spanned the entire length of the anterior urethra. And given its length, the team suspected that a bilateral inner cheek tissue would be insufficient to repair the stricture without utilizing other tissue, like adjacent skin flaps or split thickness skin grafting.
“He was a good candidate for a rectal mucosal graft, so we discussed both options. He ultimately elected to move forward with the rectal mucosa harvest urethroplasty, which was done in collaboration with our colorectal surgery colleagues,” says Dr. Wood.
This video describes the team’s approach to preoperative care, setup, SP docking, RMG harvest, urethral reconstruction, postoperative care and follow-up. Notably, the harvest was completed in less than two hours and with minimal donor site morbidity.
The SP robot is an ideal platform for harvesting a long-segment RMG for a substitution urethroplasty. Cleveland Clinic urologists have been using the SP robot for several years. Still, the technology has not been widely adopted across other specialties, likely owing to issues of cost and accessibility.
“The SP robot is a great fit for transanal surgery; it marries modern endoscopy with a technologically advanced robotic system. However, it may be unfamiliar territory for some urologists. As the technology becomes more ubiquitous and data continue to support its utility, particularly for donor site outcomes, that may start to change,” concludes Dr. Wood.
Study examines patient knowledge of urinary tract infections
July 11th 2024"The objective of this study was to assess baseline knowledge about urinary tract infections, interest in health resources, and platform preferences for health information acquisition and dissemination," says Stephanie Gleicher, MD.
Burden of care for recurrent UTI is higher for female urologists
June 15th 2024"What we believe is happening is women are seeking the help of female urologists, and therefore, because of the nature of the condition, the female urologists are absorbing the burden of the care of these patients, particularly the non-billable burden," says Debra L. Fromer, MD.
Destigmatizing Urology: Dr. Winter discusses STDs/STIs
March 22nd 2022“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.
Predictive model quantifies risk of antibiotic resistance in uUTI
May 24th 2024The predictive models identified the number of previous UTI episodes, prior β-lactam nonsusceptibility, prior fluoroquinolone treatment, Census Bureau region (particularly in the South), and race as key predictors of having a non-susceptible isolate to 3 or more antibiotic classes.